Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Val Haddon

Podiatrist St Petersburg, FL Doctor of Podiatric Medicine

NPI 1063659803 CMS profile 275459

5637 49Th St N, St Petersburg, FL 33709

Open in the dashboard

General payments

$19,349

238 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Val Haddon of St Petersburg, FL is reported in the CMS Open Payments database as having received $19,349 across 238 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,234 17
2024 General $3,302 33
2023 General $4,282 44
2022 General $2,280 29
2021 General $4,874 34
2020 General $758 30
2019 General $2,620 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Val Haddon
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Val Haddon were reported at $1,234. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Val Haddon Podiatrist median Middle half National median
2019 $2,620 $196 $72–$601 $163
2020 $758 $118 $38–$335 $114
2021 $4,874 $169 $57–$573 $132
2022 $2,280 $220 $74–$782 $149
2023 $4,282 $208 $71–$635 $160
2024 $3,302 $237 $87–$681 $164
2025 $1,234 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $9,515 117 payments
  2. Kerecis Limited $4,836 9 payments
  3. Paragon 28, Inc. $1,297 9 payments
  4. Organogenesis Inc. $1,140 34 payments
  5. Smith+Nephew, Inc. $592 21 payments
  6. DePuy Synthes Sales Inc. $478 10 payments
  7. Medline Industries, Inc. $187 2 payments
  8. Linvatec Corporation $154 1 payment
  9. Bone Support Inc. $144 1 payment
  10. Wright Medical Technology, Inc. $135 3 payments
  11. Other $872 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,889 224 payments
  2. Travel and Lodging $4,136 10 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $3,000 1 payment
  4. Education $199 2 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125 1 payment
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose Wound Care $3,000 1 payment
  2. Kerecis Omega3 Wound $3,000 1 payment
  3. Kerecis Omega3 Surgibind $3,000 1 payment
  4. Kerecis Omega3 GraftGuide Wound Care $3,000 1 payment
  5. Kerecis Omega3 SurgiClose Wound Care $1,799 6 payments
  6. ALLOWRAP $1,661 24 payments
  7. Kerecis Omega3 GraftGuide Wound Care $1,640 4 payments
  8. Kerecis Omega3 SurgiClose Wound Care $1,570 3 payments
  9. Kerecis Omega3 SurgiClose Wound Care $1,570 3 payments
  10. Kerecis Omega3 Marigen $1,570 3 payments
  11. Other $21,733 350 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

813

Median for Podiatry: 160

Drug cost

$14,006

Median for Podiatry: $2,368

Branded share of claims

16.1%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 552 $10,637
Cephalexin Generic 57 $996
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 89 $786
Ketoconazole Generic 26 $638
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 28 $338
Ciprofloxacin Hcl Generic 13 $201
Doxycycline Hyclate Generic 17 $200
Acetaminophen-Codeine Acetaminophen With Codeine Brand 14 $119
Gabapentin Generic 17 $91

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$124,762

Of which drugs: $16,105

Medicare patients

361

Average age 77

Services billed

1,753

188 women, 173 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Diabetes 55%
Ischemic heart disease 49%
Chronic kidney disease 43%
COPD 30%
Heart failure 25%
Atrial fibrillation 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 28 78 $6

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

238 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record